Soru

Zorluk: OrtaOrdering Laboratory Tests

A 4242-year-old female high school teacher presents to the clinic reporting progressive weight gain of 1212 kg over the past 11 year, easy bruising, and new-onset facial hair growth. She also reports worsening fatigue and difficulty climbing stairs due to proximal muscle weakness. On examination, her blood pressure is 164/96164/96 mmHg. She exhibits prominent supraclavicular fat pads, facial plethora, and wide, purplish abdominal striae. A diagnostic evaluation for suspected hypercortisolism is initiated.

Arrange the following diagnostic tests in the most appropriate chronological sequence for evaluating this patient, from initial diagnostic screening to the most advanced localization study.

  1. 12424-hour urine free cortisol assay
  2. 2Plasma adrenocorticotropic hormone (ACTH) measurement
  3. 3High-dose (88-mg) dexamethasone suppression test
  4. 4Bilateral inferior petrosal sinus sampling (IPSS) for ACTH

Cevap

The correct diagnostic sequence is: 1) 2424-hour urine free cortisol assay to confirm hypercortisolism; 2) Plasma ACTH measurement to determine ACTH dependence; 3) High-dose dexamethasone suppression test to initially differentiate pituitary from ectopic sources; and 4) Bilateral inferior petrosal sinus sampling (IPSS) for definitive localization if non-invasive testing is equivocal.
The correct sequence adheres to the standard endocrine principles for evaluating suspected hormone excess: first, confirm the biochemical diagnosis of the hormone excess (urine free cortisol); second, identify the regulatory driver (plasma ACTH); third, localize the anatomical source through non-invasive dynamic testing (high-dose dexamethasone suppression); and fourth, proceed to invasive sampling (IPSS) only when non-invasive localization is inconclusive.

Adım Adım Çözüm

1
Confirm the presence of pathological hypercortisolism
Perform initial screening using a 2424-hour urine free cortisol, late-night salivary cortisol, or 11-mg overnight dexamethasone suppression test.
Clinical features of Cushing syndrome overlap with common conditions like obesity; biochemical confirmation of excess cortisol is mandatory before localizing the source to avoid false-positive diagnostic cascades.
2
Determine the ACTH dependence of the hypercortisolism
Measure the plasma ACTH level.
This critically differentiates ACTH-independent causes (such as adrenal tumors or hyperplasia, where ACTH is suppressed) from ACTH-dependent causes (pituitary or ectopic ACTH secretion).
3
Differentiate the source of ACTH-dependent hypercortisolism non-invasively
Perform a high-dose (88-mg) dexamethasone suppression test.
Pituitary adenomas causing Cushing disease typically retain some negative feedback response and will suppress cortisol production with high-dose dexamethasone, whereas ectopic ACTH-secreting tumors usually do not suppress.
4
Definitively localize the ACTH source using invasive sampling
Perform bilateral inferior petrosal sinus sampling (IPSS) for ACTH.
If pituitary MRI is unrevealing or discordant with the high-dose dexamethasone test, IPSS provides a direct measurement of central versus peripheral ACTH to definitively diagnose a pituitary microadenoma.

Anahtar Kavram

The diagnostic algorithm for Cushing syndrome requires confirming hypercortisolism first, determining ACTH dependence second, and finally localizing the exact source using dynamic suppression tests followed by invasive venous sampling if needed.
Bu soruyu puanla